Physician profile
Patrick B Ball
NPI 1447236831
$657.25
in general payments reported to CMS, 2019-2025
11 companies · $19.06 in 2025
The $19.06 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $247 · 2020: $217 · 2021: $174 · 2025: $19.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $19.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $278.34 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $88.32 | 2019-2021 | |
| Novo Nordisk INC | $63.06 | 2019-2025 | Rybelsus, Ozempic |
| Amarin Pharma, INC. | $56.54 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $46.68 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $37.57 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $33.25 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.78 | 2019 | |
| Abbvie INC. | $13.13 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $13.09 | 2019 | |
| Allergan, INC. | $12.49 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.